SCOLR Pharma, Inc. (AMEX: DDD), a specialty pharmaceutical company, focuses on developing and liscensing Controlled Delivery Technology (CDT®). This technology platform contains multiple patented oral drug delivery technologies for prescription, OTC and nutritional compounds. Through alliances with pharmaceutical and natural products industry companies, SCOLR co-develops new products and adds value as well as protection to existing product franchises. For further information, visit the Company’s web site at www.scolr.com.
- 17 years ago
QualityStocks
SCOLR Pharma, Inc. (AMEX: DDD)
Tags Rodman & Renshaw
Related Post
-
Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer
The global rare disease treatment market was estimated at $195.2 billion in 2024 and is…
-
Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Is ‘One to Watch’
High-Grade Copper Opportunity: 100% ownership of the New Craigmont Project, one of British Columbia’s most promising…
-
QualityStocksNewsBreaks – Onar Holding Corporation (OTCQB: ONAR) Appoints Industry Veteran Jon Bond to Board of Directors
Onar (OTCQB: ONAR) announced the appointment of marketing pioneer Jon Bond to its board of…